PENTAMIDINE ISETIONATE FOR INJECTION BP 300 MG
PENTAMIDINE ISETIONATE : 300 MG · DIN 02517663 · MARCAN PHARMACEUTICALS INC
Health Canada status: MARKETED
What is PENTAMIDINE ISETIONATE FOR INJECTION BP?
PENTAMIDINE ISETIONATE FOR INJECTION BP 300 MG contains PENTAMIDINE ISETIONATE : 300 MG. It is listed in the Health Canada Drug Product Database under DIN 02517663, held by MARCAN PHARMACEUTICALS INC, supplied as POWDER FOR SOLUTION for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 14-Oct-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02517663 |
|---|---|
| Brand name | PENTAMIDINE ISETIONATE FOR INJECTION BP |
| Generic / active ingredient | PENTAMIDINE ISETIONATE : 300 MG |
| Manufacturer | MARCAN PHARMACEUTICALS INC |
| Strength | 300 MG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR ; INTRAVENOUS |
| Schedule | Prescription |
| ATC code | P01CX01 PENTAMIDINE ISETHIONATE |
| AHFS class | 84:04.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 14-Oct-2021 |
Is PENTAMIDINE ISETHIONATE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by MARCAN PHARMACEUTICALS INC, last seen 21 Aug 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for PENTAMIDINE ISETIONATE FOR INJECTION BP
What can be used instead?
Other Canadian products sharing ATC code P01CX01 PENTAMIDINE ISETHIONATE. 2 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PENTAMIDINE ISETIONATE FOR INJECTION BP | 300 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02183080 |
| PENTACARINAT 300 INJ PWS 300MG/VIAL | 300 MG | POWDER FOR SOLUTION | AVENTIS PHARMA INC | CANCELLED POST MARKET | DIN 01926748 |
| PENTAMIDINE ISETHIONATE INJ 300MG/VIAL BP | 300 MG | POWDER FOR SOLUTION | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 00886874 |
Who else supplies PENTAMIDINE ISETHIONATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PENTAMIDINE ISETHIONATE appears in 2 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.